Walter and Eliza Hall Institute

The Walter and Eliza Hall Institute of Medical Research is Australia's oldest medical research institute. In 2011, the institute is home to more than 650 researchers who are working to understand, prevent and treat diseases including blood, breast and ovarian cancers; inflammatory diseases (autoimmunity) such as rheumatoid arthritis, type 1 diabetes and coeliac disease; and infectious diseases such as malaria, HIV and hepatitis B and C. Located in Parkville, Melbourne, it is closely associated with The University of Melbourne and The Royal Melbourne Hospital. The institute also has a campus at La Trobe University. The institute was founded in 1915 using funds from a trust established by Eliza Hall following the death of her husband Walter Russell Hall. The institute owes its origin to the inspiration of Harry Brookes Allen, who encouraged the use of a small portion of the charitable trust to found a medical research institute. The vision was for an institute that 'will be the birthplace of discoveries rendering signal service to mankind in the prevention and removal of disease and the mitigation of suffering.’

Address
Victoria, Australia
Website
http://www.wehi.edu.au/
Wikipedia
http://en.wikipedia.org/wiki/Walter_and_Eliza_Hall_Institute_of_Medical_Research

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Cancer

Cancer blood test trialed to prevent unnecessary chemo

Cancer patients could be spared unnecessary chemotherapy—and its side effects—by a new blood test that is in clinical trials at more than 40 hospitals in Australia and New Zealand.

Cancer

New clues about how our body guards against cancer

Walter and Eliza Hall Institute researchers have uncovered a key factor protecting against age-related DNA damage, providing important clues about how our body guards against cancer.

Cancer

Discovery paves way for improved ovarian cancer care

Australian scientists have revealed a better way to identify which patients should respond to powerful ovarian cancer drugs called PARP inhibitors (PARPi), resolving an important question in ovarian cancer care about why ...

page 1 from 9